Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Choice of dopaminergic therapy among early, mild Parkinson disease subjects in North America
HTML
Details
Locations
Year:
2016
Type:
article
Source:
Journal of the Neurological Sciences
DOI:
10.1016/j.jns.2016.04.021
Authors:
John L. Goudreau,
Adriana Pérez,
Michael J. Aminoff,
James T. Boyd,
Keith D. Burau,
Chadwick W. Christine,
Maureen Leehey,
John C. Morgan
show all 8
Institutions:
Michigan State University,
The University of Texas Health Science Center at Houston,
University of California, San Francisco,
University of Vermont,
University of Vermont Medical Center,
University of Colorado Anschutz,
University of Colorado Denver,
Augusta University
show all 8
Language:
English
Topic:
Parkinson's Disease Mechanisms and Treatments
Subfield:
Neurology
Field:
Medicine
Domain:
Health Sciences
SDG:
Good health and well-being
Open Access status:
closed
Funders:
H. Lundbeck A/S,
National Institute of Neurological Disorders and Stroke
Award:
Parkinson's Disease Neuroprotection Trial
OpenAlex ID:
W2338623552
FWCI:
0.754
Cites:
33
Cited by:
7
Related to:
10